268
Participants
Start Date
July 16, 2014
Primary Completion Date
March 14, 2018
Study Completion Date
July 16, 2019
Abiraterone Acetate
Subjects administered 4 tablets abiraterone acetate twice daily in 28-day cycle.
Placebo
Subjects administered 4 tablets abiraterone acetate blank analog tablet twice daily in 28-day cycle.
Prednisone
Subjects administered 5mg prednisone twice daily in 28-day cycle.
Peking Union Medical College Hospital, Beijing
Peking University First Hospital, Beijing
Harbin Medical University Cancer Hospital, Harbin
Fudan University Medical College Affiliated Huadong Hospital, Shanghai
Fudan University Shanghai Cancer Center, Shanghai
RenJi Hospital of Shanghai Jiaotong University School of Medicine, Shanghai
Jiangsu Province Hospital, Nanjing
Qilu Hospital of Shandong University, Jinan
The Second Affiliated Hospital of Zhenjiang University School of Medicine, Hangzhou
Chongqing Cancer Hospital, Chongqing
Guangzhou Military Region Wuhan General Hospital, Wuhan
TongJi medical college of HuaZhong University of Science & Technology Affiliated TongJi Hospital, Wuhan
Henan Cancer Hospital, Zhengzhou
Sun-Yat-Sen University Cancer Center, Guangzhou
The First Affiliated Hospital of Guangxi Medical University, Nanning
West China Hospital，Sichuan University, Chengdu
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY